- $74.04bn
- $76.85bn
- $32.68bn
- 94
- 51
- 86
- 91
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32,136 | 32,184 | 35,355 | 34,229 | 32,681 |
Cost of Revenue | |||||
Gross Profit | 15,072 | 15,643 | 16,579 | 15,000 | 14,305 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 25,998 | 25,033 | 27,997 | 27,690 | 41,809 |
Operating Profit | 6,138 | 7,151 | 7,358 | 6,539 | -9,128 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,643 | 6,795 | 7,204 | 6,392 | -9,688 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,529 | 5,458 | 5,919 | 5,780 | -6,997 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4,517 | 5,449 | 5,921 | 5,777 | -6,995 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,517 | 5,449 | 5,921 | 5,777 | -6,995 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.03 | 9.12 | 10.3 | 10.6 | 9.36 |
Dividends per Share |